PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 192 filers reported holding PACIRA PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 1.40 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $3,124,000 | -51.0% | 58,965 | -28.7% | 0.01% | -54.5% |
| Q4 2015 | $6,371,000 | +1836.5% | 82,720 | +934.0% | 0.01% | +1000.0% |
| Q3 2015 | $329,000 | -91.6% | 8,000 | -81.9% | 0.00% | -85.7% |
| Q1 2015 | $3,926,000 | -52.2% | 44,195 | -52.4% | 0.01% | -50.0% |
| Q4 2014 | $8,210,000 | -17.7% | 92,842 | -9.8% | 0.01% | -22.2% |
| Q3 2014 | $9,974,000 | -11.0% | 102,911 | -15.7% | 0.02% | -10.0% |
| Q2 2014 | $11,213,000 | +39.5% | 122,071 | +6.3% | 0.02% | +42.9% |
| Q1 2014 | $8,036,000 | +59.2% | 114,827 | +55.3% | 0.01% | +55.6% |
| Q4 2013 | $5,048,000 | +74.8% | 73,959 | +23.2% | 0.01% | +80.0% |
| Q3 2013 | $2,888,000 | +76.9% | 60,046 | +6.6% | 0.01% | +66.7% |
| Q2 2013 | $1,633,000 | – | 56,317 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GAGNON SECURITIES LLC | 563,415 | $21,753,453 | 4.80% |
| Gagnon Advisors, LLC | 180,331 | $6,962,579 | 4.70% |
| Spyglass Capital Management LLC | 868,686 | $33,539,966 | 2.69% |
| Tamarack Advisers, LP | 100,000 | $3,861,000 | 1.99% |
| ARMISTICE CAPITAL, LLC | 1,892,000 | $73,050,120 | 1.27% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 276,590 | $10,679,140 | 0.99% |
| RICE HALL JAMES & ASSOCIATES, LLC | 437,285 | $16,883,574 | 0.97% |
| Rock Springs Capital Management LP | 1,032,600 | $39,868,686 | 0.96% |
| OUTFITTER FINANCIAL LLC | 25,860 | $998,455 | 0.91% |
| Stephens Investment Management Group LLC | 1,168,469 | $45,535,237 | 0.82% |